glp-1 agonist or antagonist Glucagon-like peptide-1 The Premise of the Paradox:

Aspiration pneumonia has been reported

At the same time, these medications cross the blood-brain barrier and directly signal satiety at the hypothalamus

Dietary patterns that support GLP-1 biology may also help people tolerate GLP-1 receptor agonist (GLP-1RA) therapy by reducing gastrointestinal side effects, which are a frequent reason for discontinuation in clinical practice

However, people with underlying conditions like a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), or severe gastrointestinal disease should avoid semaglutide injections and consult medical professionals at a weight loss clinic for alternative options

A common mechanism is enzyme inhibition or induction, particularly involving cytochrome P450 (CYP) enzymes

GLP-1 Receptor Agonist Market Overview and Key Insights: The GLP-1 Receptor Agonist market size reached USD 15.25 Billion in 2024 and is expected to register a revenue CAGR of 21.7% during the forecast period